Flowserve swing check valves help increase reliability in chemical applications
Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability
The new design introduces casting technology in lieu of forgings, which reduces the weight of the valve by 45% and offers enhanced bonnet-seal performance. The valve features a recessed hinge pin that is protected from the flow path, integral seat design and a high integrity riveted disc assembly. The valve can be installed horizontally or vertically.
'Flowserve's foundry specialises in the alloys and highly engineered casting processes that helped to create the redesigned Noble Alloy swing check valve,' said Brian Hood, product manager, Flowserve Flow Control Division. 'Even in the most challenging applications, this valve delivers improved performance for customers" most severe applications while helping reduce life-cycle costs.'
The Noble Alloy swing check valve is available with soft or metal seating. It features multiple end connections and bolted bonnet construction.
Noble Alloy also offers a wafer piston check design in cast and forged technology. Forged metal construction remains available for all Noble Alloy valve designs.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
New Flowserve digital positioner features predictive diagnostics
Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics